SCOPUS 정보 검색 플랫폼

Journal of the American Academy of Dermatology

Volumn 57, Issue 5 SUPPL., 2007, Pages

Treatment of ichthyosiform diseases with topically applied tazarotene: Risk of systemic absorption

(5) Nguyen, Victoria a,b Cunningham, Bari B a Eichenfield, Lawrence F a Alió, Alessandra B a Buka, Robert L a,c

a RADY CHILDREN'S HOSPITAL (United States)

b SANTA CLARA VALLEY MEDICAL CENTER (United States)

c MOUNT SINAI SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID; TAZAROTENE;

ARTICLE; CHILD CARE; COMORBIDITY; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; DRUG ABSORPTION; DRUG BLOOD LEVEL; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; RISK ASSESSMENT; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ICHTHYOSIS; MALE; NICOTINIC ACIDS; RISK FACTORS;

EID: 35248854984 PISSN: 01909622 EISSN: None Source Type: Journal
DOI: 10.1016/j.jaad.2006.05.028 Document Type: Article

Times cited : (19)

References (7)

1
- 0025989195
- Acitretin in the treatment of severe disorders of keratinization
- Blanchet-Bardon C., Nazzaro V., Rognin C., Geiger J.M., and Puissant A. Acitretin in the treatment of severe disorders of keratinization. J Am Acad Dermatol 24 (1994) 982-986
- (1994) J Am Acad Dermatol , vol.24 , pp. 982-986
- Blanchet-Bardon, C.¹ Nazzaro, V.² Rognin, C.³ Geiger, J.M.⁴ Puissant, A.⁵

2
- 0032716344
- Effect of topical tazarotene in the treatment of congenital ichthyoses
- Hofmann B., Stege H., Ruzicka T., and Lehmann P. Effect of topical tazarotene in the treatment of congenital ichthyoses. Br J Dermatol 141 (1999) 642-646
- (1999) Br J Dermatol , vol.141 , pp. 642-646
- Hofmann, B.¹ Stege, H.² Ruzicka, T.³ Lehmann, P.⁴

3
- 0031945968
- Topical application of tazarotene in the treatment of nonerythrodermic lamellar ichthyosis
- Stege H., Hofmann B., Ruzicka T., and Lehmann P. Topical application of tazarotene in the treatment of nonerythrodermic lamellar ichthyosis. Arch Dermatol 134 (1998) 640-641
- (1998) Arch Dermatol , vol.134 , pp. 640-641
- Stege, H.¹ Hofmann, B.² Ruzicka, T.³ Lehmann, P.⁴

4
- 0038045493
- Type I lamellar ichthyosis improved by tazarotene 0.1% gel
- Marulli G.C., Campione E., Chimenti M.S., Terinoni A., Mleino G., and Bianchi L. Type I lamellar ichthyosis improved by tazarotene 0.1% gel. Clin Exp Dermatol 28 (2003) 391-393
- (2003) Clin Exp Dermatol , vol.28 , pp. 391-393
- Marulli, G.C.¹ Campione, E.² Chimenti, M.S.³ Terinoni, A.⁴ Mleino, G.⁵ Bianchi, L.⁶

5
- 0029827538
- Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis
- Weinstein G.D. Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis. Br J Dermatol 135 Suppl (1996) 32-36
- (1996) Br J Dermatol , vol.135 , Issue.SUPPL , pp. 32-36
- Weinstein, G.D.¹

6
- 0030800141
- Clinical safety of tazarotene in the treatment of plaque psoriasis
- Marks R. Clinical safety of tazarotene in the treatment of plaque psoriasis. J Am Acad Dermatol 37 Suppl (1997) S25-S32
- (1997) J Am Acad Dermatol , vol.37 , Issue.SUPPL
- Marks, R.¹

7
- 0032697030
- Clinical pharmacokinetics and drug metabolism of tazarotene
- Tang-Liu D.D.-S., Matsumoto R.M., and Usansky J.I. Clinical pharmacokinetics and drug metabolism of tazarotene. Clin Pharmacokinet 37 (1999) 273-287
- (1999) Clin Pharmacokinet , vol.37 , pp. 273-287
- Tang-Liu, D.D.-S.¹ Matsumoto, R.M.² Usansky, J.I.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.